1. Home
  2. WAL vs HALO Comparison

WAL vs HALO Comparison

Compare WAL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAL
  • HALO
  • Stock Information
  • Founded
  • WAL 1994
  • HALO 1998
  • Country
  • WAL United States
  • HALO United States
  • Employees
  • WAL N/A
  • HALO N/A
  • Industry
  • WAL Major Banks
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WAL Finance
  • HALO Health Care
  • Exchange
  • WAL Nasdaq
  • HALO Nasdaq
  • Market Cap
  • WAL 7.8B
  • HALO 7.4B
  • IPO Year
  • WAL 2005
  • HALO N/A
  • Fundamental
  • Price
  • WAL $78.18
  • HALO $52.02
  • Analyst Decision
  • WAL Strong Buy
  • HALO Buy
  • Analyst Count
  • WAL 15
  • HALO 9
  • Target Price
  • WAL $95.13
  • HALO $63.56
  • AVG Volume (30 Days)
  • WAL 1.0M
  • HALO 3.1M
  • Earning Date
  • WAL 04-21-2025
  • HALO 05-06-2025
  • Dividend Yield
  • WAL 1.93%
  • HALO N/A
  • EPS Growth
  • WAL 6.13
  • HALO 55.40
  • EPS
  • WAL 7.28
  • HALO 3.76
  • Revenue
  • WAL $3,049,400,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • WAL $13.26
  • HALO $24.79
  • Revenue Next Year
  • WAL $9.87
  • HALO $22.65
  • P/E Ratio
  • WAL $10.85
  • HALO $13.83
  • Revenue Growth
  • WAL 11.37
  • HALO 25.64
  • 52 Week Low
  • WAL $56.70
  • HALO $41.28
  • 52 Week High
  • WAL $98.10
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • WAL 61.58
  • HALO 39.78
  • Support Level
  • WAL $70.45
  • HALO $47.50
  • Resistance Level
  • WAL $80.47
  • HALO $69.94
  • Average True Range (ATR)
  • WAL 2.11
  • HALO 3.52
  • MACD
  • WAL 1.07
  • HALO -1.49
  • Stochastic Oscillator
  • WAL 78.52
  • HALO 19.64

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: